Lead Product(s) : Potassium Bromide
Therapeutic Area : Neurology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : KBro-Vet-CA1 meets the criteria of conditional approval under the expanded authority, as there is currently no animal drug approved and marketed in the U.S. for the treatment of idiopathic epilepsy in dogs.
Brand Name : KBroVet-CA1
Molecule Type : Small molecule
Upfront Cash : Not Applicable
January 14, 2021
Lead Product(s) : Potassium Bromide
Therapeutic Area : Neurology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?